Bacteromic Sp. z o.o. is a part of the Scope Fluidics Group and was established to develop the BACTEROMIC system, used to assess the drug susceptibility of microorganisms.
The BACTEROMIC system enables phenotypic evaluation of the efficacy of antibiotics, used to treat infections of the respiratory system, blood, urinary tract, skin, and other areas. It also has the capability to detect resistance mechanisms. Thanks to the determination and expertise of a multidisciplinary team of biotechnologists, engineers and software developers, and their innovative approach to modern diagnostics, this device holds significant market potential and the ability to revolutionize antibiotic treatment.
Company Details
- Employees
- 51
- Founded
- -
- Address
- Ogrodowa 58, 58,poland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.bacteromic.com
- Keywords
- teams..
- HQ
- Wola, Masovian Voivodeship
Bacteromic Questions
Bacteromic's website is http://www.bacteromic.com
Bacteromic's LinkedIn profile is https://pl.linkedin.com/company/joinbacteromic
Bacteromic has
51 employees.
View email and phone details for 51
employees at Bacteromic.
Bacteromic's industry is
Biotechnology Research
Bacteromic's top competitors are
Scope Fluidics,
Fresh Inset S.a.,
Medinice S.a.,
International Institute Of Molecular And Cell Biology In Warsaw,
Selvita,
Adamed Pharma,
Bioceltix,
Molecure,
Medisensonic,
Explorna Therapeutics.
Bacteromic's categories are Biotechnology Research
Bacteromic's founding year is 2017
